Manual Lymphatic Drainage

Origins in the Vodder account

The Dr. Vodder School, a training organization, hosts an account by Hildegard Wittlinger (copyright 2004). It states that Emil Vodder, born in Copenhagen in 1896 and holder of a 1928 doctorate from the University of Brussels for a thesis on historical art, moved with his wife Estrid to the French Riviera in 1929. There he began treating patients and studying the lymphatic system, and the account says he palpated and massaged swollen cervical lymph nodes. It places the couple's move to Paris in 1933.

The same account says Vodder presented the method at a congress in Paris in 1936 under the name Manual Lymph Drainage ad modum Vodder. This is a school's own history of its founder, and it was the only account of the method's origin opened for this page. A PubMed search for historical reviews of Vodder's work returned no results, so these dates are unconfirmed by independent scholarship.

Spread and clinical adoption

According to the Vodder School account, invitations to teach arrived from European countries in the early 1950s, a German physician drew up a first list of indications in the early 1960s, and an association for the method was founded in 1967. The account adds that research by Mislin on lymph angions in the 1970s was taken to support the method's effects, and that adding bandaging led to combined decongestive therapy, which German health insurers later reimbursed.

The British Lymphology Society (BLS) states that manual lymphatic drainage (MLD) has been an established part of lymphedema treatment in several European countries since the 1930s and was first used in the UK in the 1980s, when UK services lacked trained staff and training opportunities.

Continuity with current practice

A 2025 case report by authors affiliated with the Dr. Vodder School describes a two-phase lymphedema program, an initial reduction phase followed by maintenance, as standard for over half a century, and cites a Vodder textbook for the technique. Current practice therefore combines the hand technique with decades of added compression and exercise. Trials have used different MLD methods, so results from one method should not be assumed to apply to another.

Names and spellings

Sources use manual lymph drainage and manual lymphatic drainage interchangeably, both abbreviated MLD. The Vodder School gives the original name as Manual Lymph Drainage ad modum Vodder, and trial reports refer to the Vodder technique, the Vodder II method and the Vodder maneuver. The Cochrane review describes MLD as a light, very specific hands-on therapy intended to reduce lymph swelling by enhancing lymphatic drainage, which states the aim of the technique and is not a demonstrated mechanism.

Related methods and combined programs

Liang and colleagues report that the trials in their review used mostly the Vodder method and some the Földi method. A 2020 crossover trial compared Vodder and Godoy neck maneuvers, and its authors contrast the Vodder maneuvers, which produce skin traction, with the Godoy maneuvers, which slide over the skin.

Cochrane describes complex decongestive therapy (CDT) as a four-part conservative program of MLD, compression therapy, skin care and lymph-reducing exercises, and the BLS also uses the term decongestive lymphatic therapy. The BLS states that it neither endorses nor decries any of the MLD methods in current use in the UK.

Self lymphatic drainage

The BLS defines self lymphatic drainage (SLD) as a simplified version of MLD that is taught to a person or carer for self-management. MLD is described as an intensive treatment delivered by a trained therapist, so the two labels refer to different activities, and findings about one should not be applied automatically to the other.

Technique

The 2025 case report describes Vodder principles as circular movements of the skin that apply stretching and shearing forces to the tissue beneath, which the authors say increase lymph formation and flow. Pressure is adapted to the presentation, with stronger pressure used to soften fibrotic areas, and the strokes aim to redirect fluid toward alternative drainage pathways. These are the authors' descriptions and not measured outcomes.

A trial in healthy students described the technique as very light, pain-free, rhythmical movements of the skin. In that trial each session lasted 15 minutes at 20 to 30 strokes per minute, delivered by one therapist with 10 years of MLD experience. The authors did not quantify the pressure and noted that future research needs a detailed description of speed, pressure and drainage direction.

Setting and session length

The BLS describes MLD as frequently used inside an intensive lymphedema program that usually includes skin care, exercise and compression bandaging, aiming to reduce limb volume, restore limb shape and improve skin condition. Some techniques begin with the trunk and others with the nodal areas next to the swelling, and all direct fluid away from the congested area. The same document gives 45 to 60 minutes for MLD, against 10 to 15 minutes for SLD.

Trial schedules varied. One trial added 30 minutes of MLD to bandaging and exercise for an intensive phase of two weeks, and a trial in hand swelling used weekly sessions for five weeks. These are trial designs and not recommended schedules.

What a participant may experience

In the healthy-student trial, participants were told that hypotension, relaxation or sleepiness, and mild dizziness were possible for 30 minutes after treatment, and they were asked about symptoms afterward. The BLS states that people receiving MLD should be monitored closely and frequently, and that treatment should continue only when a measurable clinical benefit is shown.

Lymphedema and chronic edema

MLD is used mainly for lymphedema and other chronic swelling. Cochrane notes that more than one in five people treated for breast cancer develop breast cancer-related lymphedema and that MLD is often given within CDT. The BLS says provision in the UK is variable, with some patients receiving MLD in NHS plans and others through privately reimbursed care.

The BLS states that all practitioners accept some patients benefit from MLD, while some clinics offer it as part of a standard package even for patients in whom it has minimal effect on outcome. It adds that the criteria for predicting who will benefit lack empirical evidence.

Other swelling and conditions studied

Small studies have tested MLD for facial swelling after removal of impacted third molars and for hand swelling in systemic sclerosis during its edematous phase. A further trial examined neck maneuvers in healthy students to look at effects on heart rate, blood pressure and neck movement.

None of the sources reviewed addressed claims that MLD supports immune function, removes toxins or changes body shape, so this page makes no statement about those claims. Uses described here are those reported in the trials and position documents cited.

Cochrane review of breast cancer-related lymphedema

The 2015 Cochrane review (searches to May 2013) included six randomized or quasi-randomized trials with 208 women in total. In two trials of MLD plus compression bandaging versus bandaging alone (83 participants), bandaging alone reduced excess volume by 30% to 38.6%, and MLD added a further 7.11 percentage points (95% confidence interval 1.75 to 12.47). Mild to moderate lymphedema responded better than moderate to severe, a subgroup finding the reviewers said needs confirmation.

Three trials comparing MLD with other treatments were too varied to pool, with inconsistent volume results. Function and quality of life results were contradictory or unusable, and pain and heaviness improved in both arms. Four trials did not blind the person measuring swelling.

Later meta-analysis and a noninferiority trial

A 2020 meta-analysis of 17 randomized trials (1,911 patients; searches to May 2019) examined MLD after breast cancer surgery. In 8 treatment trials (338 patients) the pooled standardized mean difference was -0.09 (95% confidence interval -0.85 to 0.67) with heterogeneity of 91.3%, and in 4 prevention trials (1,364 patients) the pooled risk ratio was 0.61 (0.29 to 1.26). The authors concluded that MLD could not significantly reduce or prevent lymphedema, citing weak randomization and unblinded assessors.

A Polish trial randomized 60 women with advanced arm lymphedema (limb volume difference of 20% or more) to bandaging and exercise, with or without 30 minutes of Vodder II MLD. Among 51 who completed 26 weeks, limb volume fell 15.6% without MLD and 13.8% with it, and edema volume fell by about 47% in both groups. The authors concluded that similar results may be obtained without MLD.

Position of the British Lymphology Society

The BLS position document (September 2024) draws on a scoping review of studies in adults with chronic edema or lymphedema to the end of 2022, grouped into five body areas. It concludes the evidence is not strong enough to endorse MLD as a standalone treatment for lymphedema of the head and neck, breast and chest, genitals, or upper and lower limbs, and calls high-quality evidence for a recommended package lacking. It accepts use within a comprehensive plan with compression and exercise when clinically justified.

Other conditions and physiological studies

A 2007 study of 10 patients compared MLD on one side of the neck with an untreated side after bilateral third molar removal. Four of six facial measurements showed less swelling on the treated side, and a discomfort scale fell from 35.5 to 22 mm. In systemic sclerosis, a 2011 study of 35 people reported lower hand volume after weekly Vodder MLD for 5 weeks in 20 treated people, with no change in 15 observed people. Both studies were small, and the findings should not be carried over to other conditions.

In 24 healthy students, neck maneuvers did not change oxygen saturation or diastolic blood pressure compared with placebo or no touch. Heart rate and systolic pressure differences were reported inconsistently, so they are not summarized. No people with health conditions were studied.

Adverse events in trials

The Cochrane review concluded that MLD was well tolerated and safe in all trials it included. Two trials reported no adverse events from MLD, no infections were reported in any trial, and the two dropouts for adverse events in one trial were attributed to bandaging. The trials were small, with 208 participants in total, so rare harms would not be expected to appear. The 2020 meta-analysis did not report adverse events.

In the healthy-student trial the authors reported no adverse effects, while participants had been told that low blood pressure, drowsiness and mild dizziness could follow treatment.

Contraindications and cautions listed by the BLS

The BLS Lymph Facts sheet on self lymphatic drainage, which covers SLD and MLD in lymphedema, lists these contraindications: acute cellulitis, infection or erysipelas; severe uncontrolled cardiac insufficiency; superior vena cava obstruction; unstable hypertension; renal failure; liver cirrhosis, especially with ascites; and acute or suspected untreated deep vein thrombosis and pulmonary embolism.

Its cautions are poorly controlled thyroid dysfunction, cardiac insufficiency, and work directly over primary tumors or metastases. The sheet states there is no evidence either supporting or refuting that SLD or MLD moves cancer cells, and that use in active cancer should rest on clinical judgment, symptom management and informed consent.

Care boundaries and practitioner standards

Because acute infection and suspected deep vein thrombosis appear among the contraindications, new swelling with redness, heat, fever, sudden onset or breathlessness calls for medical assessment before any lymphatic work. MLD does not replace assessment of the cause of swelling or necessary medical care. The BLS states that MLD should not be offered when there are indications that the person will not benefit clinically.

The sources reviewed identify no single register or training standard for MLD practitioners, and requirements differ by country. The Dr. Vodder School describes itself as a provider of education in the Vodder method, and the BLS describes MLD training in the UK as developing through varied models. A reader can ask a therapist about their training, how treatment will be monitored and when it will stop.